Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and how are you today? We apologize for our absence yesterday, but we were speaking on a panel at the Harvard University School of Public Health, which was hosting a conference on clinical trial data sharing and transparency. Yes, it seemed to go well, thank you. Now, though, there are the usual matters to occupy us. And so, we are quaffing a cup of needed stimulation before we leave the greater Boston environs to return to the blessed Pharmalot corporate campus for another long weekend. This explains the appearance of the weekly jobs column, which usually runs on Friday. Meanwhile, here are some tidbits. Have a smashing day, a wonderful weekend and do stay in touch... Clause In Iindian Foreign Investment Policy Worries Drugmakers (The Business Standard) Odd Finding Seen In Avandia And Fenofibrate Trial (MedPage Today) Teva's Interim CEO Would Welcome A Diviersified Board (The Financial Times) A Dementia Epidemic Looms With 135 Million Sufferers By 2050 (Reuters) Merck KGgA To Buy AZ Electronic Materials For $2.6 Billion (Bloomberg News) CMS Finds Mail Order Rx Is More Expensive Than Pharmacies (Drug Store News) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs